IB Net Payout Yields Model

Invest like me - only at Covestor.com

Cannabis Coverage

By -

Despite all the excitement over cannabis stocks, the sector has generally traded flat since mid-September. My research has consistently shown that the industry can too easily add supplies to meet and actually far exceed market demand.


Since 9/15, sector stocks are generally mixed around breakeven with Aurora Cannabis (ACB) up slightly and Canopy Growth (CGC) down slightly. The other big players have traded more wildly with Cronos Group (CRON) inexplicably up over 100% while Tilray (TLRY) is down over 27%.


A prime example of the problems in the industry is a secondary cannabis company like Hexo (HEXO) that recently raised about $50 million at close to the highest stock prices. No lack of capital is a big problem. Not to mention, a new player like Zenabis that plans to go from limited cannabis production to ~500K kilograms by 2020.

The large numbers thrown out regarding market sizes is attracting far too many new players.
 Below is my recent detailed coverage on cannabis stocks:

Aurora Cannabis - Aurora Cannabis: More Alarm Bells
Canopy Growth - Canopy Growth: Confusing Hype
Tilray -  Tilray: Too Good Of A Deal?


Disclosure: No position. Please review the disclaimer page for more details. 

Comments

Joseph Mikel said…
Nice article, Which you have shared here about the Cannabis. Your article is very informative and useful to know more about the market growth of Cannabis. Coffeeshop Guru is the best online store where you can Buy Sunset Sherbet Seeds at the affordable price.
August 20, 2019 at 10:49 AM
William Jessie said…
I really appreciate your work which you have shared here about the Cannabis. The article you have shared here is very informative and the points you have mentioned are very helpful. Thank you so much. If anyone looking to Buy kush online in usa, weedmailorder is a best choice.
February 22, 2020 at 5:55 AM
Anonymous said…
This is an incredible article which you have shared here about cannabis. It is a genuinely gainful article for us. Grateful to you for sharing an article like this. cannabis herbs online store
March 5, 2021 at 3:42 AM
bcseeds said…
Nice information, this information is excellent and important for everyone. I am thankful to you for providing this kind of information. shrooms orange juice
October 25, 2021 at 5:18 AM
devil Manco said…
I think this is one of the most significant pieces of information for me. And I'm glad to read your article. Thank you for sharing! cheese strain online
November 23, 2021 at 11:12 AM
jeff said…
This blog is completely informative and productive. All the things mentioned are true. Buy high quality bob Marley strain
November 27, 2021 at 4:50 PM
Post a Comment

Popular posts from this blog

Occidental: Still Producing Too Much Oil

By -
Image
Though oil continues plunging, the oil giants continue producing more. For Q4, Occidental Petroleum (OXY) had roughly flat production. The worst part is that OXY plans to grow production by 2% to 4% in 2016. The stock has held up somewhat strong, but the inability to turn off the spigot remains troubling. Disclosure: No positions mentioned. Please review the disclaimer page for more details. 
Read more

ChargePoint: Low Quality Beat

By -
Image
  ChargePoint beat FQ2'22 revenue estimates, but the losses are mounting. The company guided up FY22 numbers partly due to acquisitions. The stock still trades at an estimated 21x FY23 number leaving limited upside for the stock and reinforcing why venture funds sold 13.8 million shares. Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our model portfolio.  Learn More » After  solid FQ2'22 earnings ,  ChargePoint Holdings  ( CHPT ) has seen a nice bump in the stock. Now investors have to confront the valuation divide and deal with the past insider sales likely leading to future sales on any stock rallies. My  investment thesis  remains very Bearish on the EV charging station stock on any rallies into the mid-$20s. Read the full article on Seeking Alpha.  Disclosure: No position mentioned. Please review the disclaimer page for more details.  Update - Sept. 8 Be cautious when analysts struggle to make the bullish case on expen
Read more

Aurora Cannabis: Deal Or No Deal

By -
Aurora Cannabis was left out of the major deal making in 2018. The cannabis company updated FQ2 guidance to revenues of $50 to $55 million with a continued focus on pure production growth. The stock is down as the market is becoming less impressed with commodity farming operations due to the prime Oregon example. The stock is below key resistance at $5.40 as medical cannabis patient totals failed to impress. As the end of 2018 came and went,   Aurora Cannabis   ( ACB ) was a notable absentee from the deal making in the cannabis market. Just about all of the other major Canadian cannabis players got large investments or signed up powerful partnerships, but the related stocks didn't generally maintain rallies following the deals. Based on the early legalization data in Canada and Oregon, the best option for Aurora Cannabis might actually be selling production capacity while the Canadian market remains hot. Read the full article on Seeking Alpha.  Disclosure: No
Read more